Business & Industry
BioPharma
Trump To Roll-Out 340B Drugs Discount Program in 2026
The Trump administration is going to pilot a voluntary program in 2026, wherein the pharmaceutical companies can offer rebates for certain drugs to hospitals that...
BioPharma
60-Day Window by Trump for Firms to Lower Their...
President Donald Trump of the USA has sent letters to the drug company CEOs demanding they lower their drug prices. The letters that have been...
BioPharma
Bavarian Nordic Agrees for a $3 Bn Take-Private Offer
Bavarian Nordic, the vaccine maker, on July 28 said that it has agreed in principle for roughly $3 bn take-private offer from private equity firms...
BioPharma
South Korea – A Biopharma Innovation Hub With 113%...
The biopharmaceutical sector of South Korea has seen a growth in innovators and drug licensing agreements by way of reaching a total deal value of...
Business & Industry
EU-US Trade Deal Taking Shape as Pharma Tariffs Materialize
Finally, the Trump administration’s much-animated tariffs on pharmaceutical imports are now materializing in a new EU-US trade deal. However, there are still many questions that...
BioPharma
AstraZeneca plans to invest $50 billion in America for...
AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is...
Business & Industry
Sino BioPharm to Acquire LaNova Medicines for $950.9 M...
LaNova Medicines, which happens to be a cancer drugmaker that previously licensed medicines to AstraZeneca as well as Merck & Co., has gone on to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.